- Results from the Migraine Care support program show that employer-initiated educational and counselling support cut migraine-related disability by more than half after 6 months
- Migraine Care is a pilot employee support program offered by Novartis to its employees and their family members in Switzerland
- The program encourages managers and employees to speak up about migraine, and includes free personalized coaching calls with an independent telemedicine provider
- A study assessing the impact of Migraine Care is being presented at the 19th Congress of the International Headache Society (IHC), 5-8 September 2019
Basel, September 5, 2019 - Caroline Barth, Head of Pharma People and Organization at Novartis said: "Migraine predominantly affects people in their prime working years, resulting in a substantial impact on workplace productivity. However, the impact of migraine and headaches at work is often unseen or underestimated by employers and can be underplayed by employees in order to hold on to their jobs. One of the strategic priorities at Novartis is to unleash the power of people, encouraging them to be the best they can be. Supporting people with conditions like migraine and providing education in the workplace can result in significant benefits for both employee and employer, as demonstrated by our Migraine Care pilot program."